Search Results for “EC” – Page 145 – media

Pfizer announces second year of UK-based startup innovation competition

Pfizer announced today that it is receiving applications for its Pfizer Healthcare Hub: London competitive grant. This is the second time that Pfizer has held the startup-focused program, which representatives from biopharmaceutical company said had a strong inaugural year in 2017.
- Source: MobiHealthNews
- 673
- April 9, 2018
Company Insights healthcare Pfizer
Quick-acting ‘injectable bandage’ developed from seaweed

Researchers have developed an "injectable bandage" that quickly stops bleeding and allows wounds to heal faster than traditional dressings. Biomedical engineers at Texas A&M University in College Stations have invented the "injectable bandage," which is composed of a seaweed-derived gelling agent and two-dimensional clay nanoparticles.
- Source: upi
- 516
- April 8, 2018
injectable bandage Researches
Adherium receives OTC clearance for AstraZeneca’s Symbicort inhaler

Smart inhaler company Adherium announced last week that it has received 510(k) clearance for over-the-counter sales of its inhaler monitoring device for AstraZeneca’s Symbicort aerosol inhaler, called the SmartTouch for Symbicort.
- Source: MobiHealthNews
- 797
- April 7, 2018
COPD FDA New Approvals
Martin Pharmaceuticals Receives FDA Orphan Drug Designation For LIVANTRA™

MARTIN PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR LIVANTRA™
- Source: martinpharma
- 612
- April 4, 2018
FDA LIVANTRA™ rare (orphan) diseases
Palatin Technologies Announces Submission of Bremelanotide NDA to FDA for Treatment of Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical needs and commercial potential, announced that its exclusive North American licensee for bremelanotide, AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for bremelanotide for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. If approved, bremelanotide would become the first and only as desired pharmacologic option in the U.S. indicated for the treatment of HSDD in premenopausal women.
- Source: drugs
- 563
- April 3, 2018
bremelanotide FDA New Approvals
Record Q1 brings in $1.6B for digital health investments, disease diagnosis segment dominates

Investment in digital health rose to its highest level for the first quarter of the year at $1.6 billion compared with $909 million for the same time last year, according to a new report by Rock Health. That figure reflected investment across 77 digital health deals, dominated by the category of disease diagnosis in terms of total investment and monitoring of disease category in terms of deal volume.
- Source: MedCityNews
- 599
- April 3, 2018
Company Insights digital health investment
Device able to quickly and accurately detect stroke

A new visor-like device worn by patients can help providers and emergency medical personnel detect a stroke that requires comprehensive care within seconds and with greater than 90 percent accuracy.
- Source: Health Data Management
- 722
- April 3, 2018
FDA medical device New Approvals stroke
Leading CROs, Veeva team up for open tech on trials

Six big contract research companies, alongside Veeva Systems, are for the first time coming together to develop open technology standards aimed at “transforming clinical trial ops” to speed up development.
- Source: fiercebiotech
- 578
- March 30, 2018
Clinical Trial CRO
FDA clears Medtronic’s smartphone-connected CGM for MDI users

Medtronic has finally received FDA clearance for Guardian Connect, its smartphone-connected standalone CGM for patients who use multiple daily injections (MDI) for their insulin. Medtronic's closed-loop system for pump users was cleared in 2016.
- Source: mobihealthnews
- 810
- March 30, 2018
FDA Guardian Connect insulin Medtronic New Approvals
Charity launches biometrics wristband project for autistic people

The North-West charity aims to build the world’s first autism assessment and diagnostic centre in Wirral, where biometric technology will be used to measure physiological properties of people with autism.
- Source: MedicalPlasticsNews
- 586
- March 29, 2018
autism digital health Researches wearables

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.